Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MONOAMINE-OXIDASE INHIBITORS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 248 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Coupland, NJ; Bell, C; Potokar, JP; Bailey, JE; Nutt, DJ
      Cardiovascular reflexes during treatment of social phobia with moclobemide

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    2. Caraceni, T; Musicco, M
      Levodopa or dopamine agonists, or deprenyl as initial treatment for Parkinson's disease. A randomized multicenter study

      PARKINSONISM & RELATED DISORDERS
    3. Flint, AJ; Rifat, SL
      Nonresponse to first-line pharmacotherapy may predict relapse and recurrence of remitted geriatric depression

      DEPRESSION AND ANXIETY
    4. Veselovsky, AV; Tikhonova, OV; Skvortsov, VS; Medvedev, AE; Ivanov, AS
      An approach for visualization of the active site of enzymes with unknown three-dimensional structures

      SAR AND QSAR IN ENVIRONMENTAL RESEARCH
    5. Ling, L; Urichuk, LJ; Sloley, BD; Coutts, RT; Baker, GB; Shan, JJ; Pang, PKT
      Synthesis of N-propargylphenelzine and analogues as neuroprotective agents

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    6. Barbelivien, A; Nyman, L; Haapalinna, A; Sirvio, J
      Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks

      PHARMACOLOGY & TOXICOLOGY
    7. Artigas, F
      Limitations to enhancing the speed of onset of antidepressants - Are rapidaction antidepressants possible?

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    8. Grasing, K; Azevedo, R; Karuppan, S; Ghosh, S
      Biphasic effects of selegiline on striatal dopamine: Lack of effect on methamphetamine-induced dopamine depletion

      NEUROCHEMICAL RESEARCH
    9. Ban, TA
      Pharmacotherapy of depression: a historical analysis

      JOURNAL OF NEURAL TRANSMISSION
    10. Kumagai, T; Ido, T; Araki, T; Matsubara, M; Imai, Y
      Riluzole protects against MPTP-induced dopamine and DOPAC depletion in mice

      BIOGENIC AMINES
    11. Torta, R; Berra, C; Ambrosino, A; Scalabrino, A
      Therapeutic aspects of depression in the elderly

      ARCHIVES OF GERONTOLOGY AND GERIATRICS
    12. Marangell, LB
      Switching antidepressants for treatment-resistant major depression

      JOURNAL OF CLINICAL PSYCHIATRY
    13. Haddad, PM
      Antidepressant discontinuation syndromes - Clinical relevance, prevention and management

      DRUG SAFETY
    14. Kulkarni, SK; Kaur, G
      Pharmacodynamics of drug-induced weight gain

      DRUGS OF TODAY
    15. Van Ameringen, M; Mancini, C; Farvolden, P; Oakman, J
      Drugs in development for social anxiety disorder: more to social anxiety than meets the SSRI

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    16. Genin, MJ
      Recent progress with oxazolidinone antibacterial agents

      EXPERT OPINION ON THERAPEUTIC PATENTS
    17. Baker, GB; Coutts, RT; Greenshaw, AJ
      Neurochemical and metabolic aspects of antidepressants: an overview

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    18. Thase, ME; Friedman, ES; Howland, RH
      Venlafaxine and treatment-resistant depression

      DEPRESSION AND ANXIETY
    19. Rose, LM; Ohlinger, WJ; Mauro, VF
      A hypertensive reaction induced by concurrent use of selegiline and dopamine

      ANNALS OF PHARMACOTHERAPY
    20. Cyr, M; Farrar, MK
      Treatment for posttraumatic stress disorder

      ANNALS OF PHARMACOTHERAPY
    21. Popper, CW
      Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder

      CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA
    22. Dalton, SO; Johansen, C; Mellemkjaer, L; Sorensen, HT; McLaughlin, JK; Olsen, J; Olsen, JH
      Antidepressant medications and risk for cancer

      EPIDEMIOLOGY
    23. Szabadi, E; Bradshaw, CM
      Mechanisms of action of reboxetine

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    24. Mercuri, NB; Federici, M; Marinelli, S; Bernardi, G
      Tranylcypromine, but not moclobemide, prolongs the inhibitory action of dopamine on midbrain dopaminergic neurons: An in vitro electrophysiological study

      SYNAPSE
    25. Baumann, MH; Ayestas, MA; Dersch, CM; Brockington, A; Rice, KC; Rothman, RB
      Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: Therapeutic implications

      SYNAPSE
    26. Broocks, A; Junghanns, K; Thiel, A; Gleiter, CH; Bandelow, B
      Advances in the pharmacotherapy of depression by new antidepressants

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    27. Montastruc, JL; Chaumerliac, C; Desboeuf, K; Manika, M; Bagheri, H; Rascol, O; Lapeyre-Mestre, M
      Adverse drug reactions to selegiline: A review of the French Pharmacovigilance Database

      CLINICAL NEUROPHARMACOLOGY
    28. Rothman, RB; Baumann, MH
      Neurochemical mechanisms of phentermine and fenfluramine: Therapeutic and adverse effects

      DRUG DEVELOPMENT RESEARCH
    29. Davids, E; Roschke, J; Klawe, C; Grunder, G; Schmoldt, A
      Tranylcypromine abuse associated with delirium and thrombocytopenia

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    30. Davidson, JRT
      Defining an appropriate management strategy for social anxiety disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    31. Song, W; Zhou, LJ; Zheng, SX; Zhu, XZ
      Amyloid-beta 25-35 peptide induces expression of monoamine oxidase B in cultured rat astrocytes

      ACTA PHARMACOLOGICA SINICA
    32. Pascoe, PJ
      Perioperative pain management

      VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE
    33. Nelson, JC
      Augmentation strategies in depression 2000

      JOURNAL OF CLINICAL PSYCHIATRY
    34. Marangell, LB
      Augmentation of standard depression therapy

      CLINICAL THERAPEUTICS
    35. Clarke, RW; Harris, J; Ogilvie, J
      Imidazoline I-2-receptors and spinal reflexes in the decerebrated rabbit

      NEUROPHARMACOLOGY
    36. Mason, PJ; Morris, VA; Balcezak, TJ
      Serotonin syndrome - Presentation of 2 cases and review of the literature

      MEDICINE
    37. Gilliland, SL; Alper, RH; Levant, B
      Pharmacology of quinpirole-stimulated [S-35]GTP gamma S binding: discrepancy with receptor binding profile

      EUROPEAN JOURNAL OF PHARMACOLOGY
    38. Thase, ME; Sachs, GS
      Bipolar depression: Pharmacotherapy and related therapeutic strategies

      BIOLOGICAL PSYCHIATRY
    39. Pozdnev, VF; Axenova, LN; Medvedev, AE
      Monoamine oxidase inhibition by N-alkyloxycarbonyl derivatives of ethylenediamine

      BIOCHEMISTRY-MOSCOW
    40. Koupparis, LS
      Harmless herbs: a cause for concern?

      ANAESTHESIA
    41. Karasu, TB; Gelenberg, A; Wang, P; Merriam, A; McIntyre, JS; Charles, SC; Zarin, DA; Altshuler, K; Tasman, A; Cook, I; Twemlow, S; Cross, CD; Woods, S; Egger, H; Yager, J; Moench, LA; Bittker, T; Peele, R; Clayton, P; Stabinsky, S; Das, A; Johnston, R; Flynn, L; Nininger, J; Goin, M; Urbaitis, J; Goldstein, M; D'Agostino, A; Gray, SH; Berg, J; Meltzer, H; Lurie, L; Norquist, G; Walker, RD; Davis, LS; Thaler, RM; Marcus, PB
      Practice guideline for the treatment of patients with major depressive disorder (revision)

      AMERICAN JOURNAL OF PSYCHIATRY
    42. Culver, KE; Rosenfeld, JM; Szechtman, H
      A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats

      PSYCHOPHARMACOLOGY
    43. Riedl, B; Endermann, R
      Recent developments with oxazolidinone antibiotics

      EXPERT OPINION ON THERAPEUTIC PATENTS
    44. Filip, V; Kolibas, E
      Selegiline in the treatment of Alzheimer's disease: a long-term randomizedplacebo-controlled trial

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    45. Ramasubbu, R
      Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    46. Wegerer, V; Moll, GH; Bagli, M; Rothenberger, A; Ruther, E; Huether, G
      Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    47. Scher, CS; Anwar, M
      The self-reporting of psychiatric medications in patients scheduled for elective surgery

      JOURNAL OF CLINICAL ANESTHESIA
    48. Alper, G; Girgin, FK; Ozgonul, M; Mentes, G; Ersoz, B
      MAO inhibitors and oxidant stress in aging brain tissue

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    49. Westenberg, HGM
      Facing the challenge of social anxiety disorder

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    50. Emslie, GJ; Walkup, JT; Pliszka, SR; Ernst, M
      Nontricyclic antidepressants: Current trends in children and adolescents

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    51. Callaway, JC; McKenna, DJ; Grob, CS; Brito, GS; Raymon, LP; Poland, RE; Andrade, EN; Andrade, EO; Mash, DC
      Pharmacokinetics of Hoasca alkaloids in healthy humans

      JOURNAL OF ETHNOPHARMACOLOGY
    52. Wellman, PJ; Maher, TJ
      Synergistic interactions between fenfluramine and phentermine

      INTERNATIONAL JOURNAL OF OBESITY
    53. ThyagaRajan, S; Ouadri, SK
      L-Deprenyl stimulates the release of catecholamines in the rat medial basal hypothalamus in vivo

      NEUROSCIENCE LETTERS
    54. Ott, J
      Pharmahuasca: Human pharmacology of oral DMT plus harmine

      JOURNAL OF PSYCHOACTIVE DRUGS
    55. Haddad, P
      Do antidepressants have any potential to cause addiction?

      JOURNAL OF PSYCHOPHARMACOLOGY
    56. Gillman, PK
      The serotonin syndrome and its treatment

      JOURNAL OF PSYCHOPHARMACOLOGY
    57. Florvall, L; Fagervall, I; Larsson, LG; Ross, SB
      Prodrugs of neuron-selective monoamine oxidase inhibitors: amino acid derivatives of 1-(4-aminophenyl)-2-aminopropanes

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    58. Delini-Stula, A; Baier, D; Kohnen, R; Laux, G; Philipp, M; Scholz, HJ
      Undesirable blood pressure changes under naturalistic treatment with moclobemide, a reversible MAO-A inhibitor - Results of the drug utilization observation studies

      PHARMACOPSYCHIATRY
    59. Shulman, KI; Walker, SE
      Refining the MAOI diet: Tyramine content of pizzas and soy products

      JOURNAL OF CLINICAL PSYCHIATRY
    60. Shelton, RC
      Treatment options for refractory depression

      JOURNAL OF CLINICAL PSYCHIATRY
    61. Shipov, AE; Genkina, GK; Makhaeva, GF; Malygin, VV; Volkova, RI; Roslavtseva, SA; Eremina, OY; Bakanova, EI; Mastryukova, TA; Kabachnik, MI
      A study of the action mechanism of 2-aryloxy-2-thio-1,3,2-oxazaphosphorinane series pesticides

      BIOORGANICHESKAYA KHIMIYA
    62. Cohen, C; Curet, O; Perrault, G; Sanger, DJ
      Reduction of oral ethanol self-administration in rats by monoamine oxidaseinhibitors

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    63. Pineyro, G; Blier, P
      Autoregulation of serotonin neurons: Role in antidepressant drug action

      PHARMACOLOGICAL REVIEWS
    64. Gupta, S; Droney, T; Kyser, B; Keller, P
      Selegiline augmentation of antipsychotics for the treatment of negative symptoms in schizophrenia

      COMPREHENSIVE PSYCHIATRY
    65. Perez, V; Marco, JL; Fernandez-Alvarez, E; Unzeta, M
      Relevance of benzyloxy group in 2-indolyl methylamines in the selective MAO-B inhibition

      BRITISH JOURNAL OF PHARMACOLOGY
    66. JEGHAM S; GEORGE P
      MONOAMINE-OXIDASE A AND B INHIBITORS

      Expert opinion on therapeutic patents
    67. FLINT AJ
      CHOOSING APPROPRIATE ANTIDEPRESSANT THERAPY IN THE ELDERLY - A RISK-BENEFIT ASSESSMENT OF AVAILABLE AGENTS

      Drugs & aging
    68. NAVARRO JF; DAVILA G
      PSYCHOPATHOLOGY AND SLEEP - III - DEPRESSION

      Psicologia conductual
    69. SHARAN P; SAXENA S
      TREATMENT-RESISTANT DEPRESSION - CLINICAL-SIGNIFICANCE, CONCEPT AND MANAGEMENT

      National Medical Journal of India
    70. Bruhwyler, J; Liegeois, JF; Gerardy, J; Damas, J; Chleide, E; Lejeune, C; Decamp, E; de Tullio, P; Delarge, J; Dresse, A; Geczy, J
      Comparative study of pirlindole, a selective RIMA, and its two enantiomersusing biochemical and behavioural techniques

      BEHAVIOURAL PHARMACOLOGY
    71. HENSLER JG; TRUETT KA
      EFFECT OF CHRONIC SEROTONIN-(2) RECEPTOR AGONIST OR ANTAGONIST ADMINISTRATION ON SEROTONIN-(1A) RECEPTOR SENSITIVITY

      Neuropsychopharmacology
    72. DUNCAN WC; JOHNSON KA; WEHR TA
      DECREASED SENSITIVITY TO LIGHT OF THE PHOTIC ENTRAINMENT PATHWAY DURING CHRONIC CLORGYLINE AND LITHIUM TREATMENTS

      Journal of biological rhythms
    73. DUNCAN WC; JOHNSON KA; SUTIN E; WEHR TA
      DISRUPTION OF THE ACTIVITY-REST CYCLE BY MAOI TREATMENT - DEPENDENCE ON LIGHT AND A SECONDARY VISUAL PATHWAY TO THE CIRCADIAN PACEMAKER

      Brain research bulletin
    74. MURPHY DL; KAROUM F; PICKAR D; COHEN RM; LIPPER S; MELLOW AM; TARIOT PN; SUNDERLAND T
      DIFFERENTIAL TRACE AMINE ALTERATIONS IN INDIVIDUALS RECEIVING ACETYLENIC INHIBITORS OF MAO-A (CLORGYLINE) OR MAO-B (SELEGILINE AND PARGYLINE)

      Journal of neural transmission. Supplementum
    75. Rickels, K; Schweizer, E
      Panic disorder: Long-term pharmacotherapy and discontinuation

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    76. AINSWORTH K; SMITH SE; SHARP T
      REPEATED ADMINISTRATION OF FLUOXETINE, DESIPRAMINE AND TRANYLCYPROMINE INCREASES DOPAMINE D-2-LIKE BUT NOT D-1-LIKE RECEPTOR FUNCTION IN THE RAT

      JOURNAL OF PSYCHOPHARMACOLOGY
    77. DAWSON J; KARALLIEDDE L
      DRUG-INTERACTIONS AND THE CLINICAL ANESTHETIST

      European journal of anaesthesiology
    78. WILLIS GL; ARMSTRONG SM
      ORPHAN NEURONS AND AMINE EXCESS - THE FUNCTIONAL NEUROPATHOLOGY OF PARKINSONISM AND NEUROPSYCHIATRIC DISEASE

      Brain research reviews
    79. DIETRICH DE; EMRICH HM
      THE USE OF ANTICONVULSANTS TO AUGMENT ANTIDEPRESSANT MEDICATION

      The Journal of clinical psychiatry
    80. NELSON JC
      OVERCOMING TREATMENT RESISTANCE IN DEPRESSION

      The Journal of clinical psychiatry
    81. NELSON JC
      TREATMENT OF ANTIDEPRESSANT NONRESPONDERS - AUGMENTATION OR SWITCH

      The Journal of clinical psychiatry
    82. Schweitzer, I; Tuckwell, V
      Risk of adverse events with the use of augmentation therapy for the treatment of resistant depression

      DRUG SAFETY
    83. FERIGOLO M; BARROS HMT; MARQUARDT AR; TANNHAUSER M
      COMPARISON OF BEHAVIORAL-EFFECTS OF MOCLOBEMIDE AND DEPRENYL DURING FORCED SWIMMING

      Pharmacology, biochemistry and behavior
    84. NELSON JC
      COMBINED DRUG-TREATMENT STRATEGIES FOR MAJOR DEPRESSION

      Psychiatric annals
    85. Kroenke, K; Gooby-Toedt, D; Jackson, JL
      Chronic medications in the perioperative period

      SOUTHERN MEDICAL JOURNAL
    86. ANANTH J
      TREATMENT-RESISTANT DEPRESSION

      Psychotherapy and psychosomatics
    87. DINGEMANSE J; WALLNOFER A; GIESCHKE R; GUENTERT T; AMREIN R
      PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN FLUOXETINE AND MOCLOBEMIDE IN THE INVESTIGATION OF DEVELOPMENT OF THE SEROTONIN SYNDROME

      Clinical pharmacology and therapeutics
    88. BLIER P; DEMONTIGNY C
      POSSIBLE SEROTONERGIC MECHANISMS UNDERLYING THE ANTIDEPRESSANT AND ANTI-OBSESSIVE-COMPULSIVE DISORDER RESPONSES

      Biological psychiatry
    89. DINGEMANSE J; WOOD N; GUENTERT T; OIE S; OUWERKERK M; AMREIN R
      CLINICAL-PHARMACOLOGY OF MOCLOBEMIDE DURING CHRONIC ADMINISTRATION OFHIGH-DOSES TO HEALTHY-SUBJECTS

      Psychopharmacology
    90. Bernadt, M
      Drug treatment of depression

      SEMINARS IN GENERAL ADULT PSYCHIATRY, VOLUMES 1-2
    91. KENNEDY SH
      CONTINUATION AND MAINTENANCE TREATMENTS IN MAJOR DEPRESSION - THE NEGLECTED ROLE OF MONOAMINE-OXIDASE INHIBITORS

      Journal of psychiatry & neuroscience
    92. NAGUIB M; MAGBOUL MMA; JAROUDI R
      CLINICALLY SIGNIFICANT DRUG-INTERACTIONS WITH GENERAL-ANESTHETICS - INCIDENCE, MECHANISMS AND MANAGEMENT

      CNS DRUGS
    93. RUDORFER MV; POTTER WZ
      THE ROLE OF METABOLITES OF ANTIDEPRESSANTS IN THE TREATMENT OF DEPRESSION

      CNS DRUGS
    94. FLINT AJ; RIFAT SL
      ANXIOUS DEPRESSION IN ELDERLY PATIENTS - RESPONSE TO ANTIDEPRESSANT TREATMENT

      The American journal of geriatric psychiatry
    95. HODGMAN MJ; MARTIN TG; KRENZELOK EP
      SEROTONIN SYNDROME DUE TO VENLAFAXINE AND MAINTENANCE TRANYLCYPROMINETHERAPY

      Human & experimental toxicology
    96. IVANUSA Z; HECIMOVIC H; DEMARIN V
      SEROTONIN SYNDROME

      Neuropsychiatry, neuropsychology, and behavioral neurology
    97. PATAT A; DUBRUC C; DESCHAMP C; DURRIEU G; TROCHERIE S; CIMAROSTI I; ALLAIN H; ROSENZWEIG P; GANDON JM
      EEG, MAO-A INHIBITION, PHARMACOKINETICS AND SAFETY OF BEFLOXATONE IN THE ELDERLY

      Human psychopharmacology
    98. DOAK GJ
      DISCONTINUING DRUGS BEFORE SURGERY

      Canadian journal of anaesthesia
    99. KLAPHEKE MM
      ELECTROCONVULSIVE-THERAPY CONSULTATION - AN UPDATE

      Convulsive therapy
    100. SHULMAN KI; TAILOR SAN; WALKER SE; GARDNER DM
      TAP (DRAFT) BEER AND MONOAMINE-OXIDASE INHIBITOR DIETARY RESTRICTIONS

      Canadian journal of psychiatry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/02/20 alle ore 20:55:01